{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T18:24:52Z","timestamp":1747160692062,"version":"3.40.5"},"reference-count":17,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","eu-focus.europeanurology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Urology Focus"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.euf.2024.05.016","type":"journal-article","created":{"date-parts":[[2024,6,6]],"date-time":"2024-06-06T11:38:19Z","timestamp":1717673899000},"page":"383-386","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Review of Discordance Between American Urological Association and European Association of Urology Guideline Recommendations for Testicular Cancer"],"prefix":"10.1016","volume":"10","author":[{"given":"Walter","family":"Cazzaniga","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Phillip","family":"Pierorazio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2511-3664","authenticated-orcid":false,"given":"Axel","family":"Heidenreich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"Suppl 3","key":"10.1016\/j.euf.2024.05.016_b0005","doi-asserted-by":"crossref","first-page":"S26","DOI":"10.1016\/j.injury.2022.01.047","article-title":"Clinical practice guidelines: the good, the bad, and the ugly","volume":"54","author":"Guerra-Farfan","year":"2023","journal-title":"Injury"},{"key":"10.1016\/j.euf.2024.05.016_b0010","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/j.euf.2021.10.012","article-title":"Evidence-based urology: trustworthy guidelines","volume":"7","author":"Violette","year":"2021","journal-title":"Eur Urol Focus"},{"key":"10.1016\/j.euf.2024.05.016_b0015","doi-asserted-by":"crossref","first-page":"3561","DOI":"10.1200\/JCO.21.00637","article-title":"Testicular cancer in the cisplatin era: causes of death and mortality rates in a population-based cohort","volume":"39","author":"Hellesnes","year":"2021","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.euf.2024.05.016_b0020","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/j.juro.2016.09.073","article-title":"Adherence to National Comprehensive Cancer Network guidelines for testicular cancer","volume":"197","author":"Wymer","year":"2017","journal-title":"J Urol"},{"key":"10.1016\/j.euf.2024.05.016_b0025","unstructured":"American Urological Association. Testicular cancer guidelines. Linthicum, MD: AUA; 2023."},{"key":"10.1016\/j.euf.2024.05.016_b0030","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1097\/JU.0000000000003694","article-title":"Diagnosis and treatment of early-stage testicular cancer: AUA guideline amendment 2023","volume":"211","author":"Stephenson","year":"2024","journal-title":"J Urol"},{"key":"10.1016\/j.euf.2024.05.016_b0035","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.eururo.2023.04.010","article-title":"European Association of Urology guidelines on testicular cancer: 2023 update","volume":"84","author":"Patrikidou","year":"2023","journal-title":"Eur Urol"},{"key":"10.1016\/j.euf.2024.05.016_b0040","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1001\/jamaoncol.2018.6477","article-title":"Association of inherited pathogenic variants in checkpoint kinase 2 (CHEK2) with susceptibility to testicular germ cell tumors","volume":"5","author":"AlDubayan","year":"2019","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.euf.2024.05.016_b0045","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1200\/JCO.2013.51.2715","article-title":"Longitudinal serum testosterone, luteinizing hormone, and follicle-stimulating hormone levels in a population-based sample of long-term testicular cancer survivors","volume":"32","author":"Sprauten","year":"2014","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.euf.2024.05.016_b0050","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1016\/j.juro.2007.11.080","article-title":"A 5-year followup study of asymptomatic men with testicular microlithiasis","volume":"179","author":"DeCastro","year":"2008","journal-title":"J Urol"},{"key":"10.1016\/j.euf.2024.05.016_b0055","doi-asserted-by":"crossref","first-page":"3009","DOI":"10.1200\/JCO.22.00624","article-title":"Surgery in early metastatic seminoma: a phase II trial of retroperitoneal lymph node dissection for testicular seminoma with limited retroperitoneal lymphadenopathy","volume":"41","author":"Daneshmand","year":"2023","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.euf.2024.05.016_b0060","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.eururo.2022.10.021","article-title":"Phase 2 Single-arm trial of primary retroperitoneal lymph node dissection in patients with seminomatous testicular germ cell tumors with clinical stage IIA\/B (PRIMETEST)","volume":"84","author":"Hiester","year":"2023","journal-title":"Eur Urol"},{"key":"10.1016\/j.euf.2024.05.016_b0065","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.euo.2023.06.004","article-title":"Retroperitoneal lymph node dissection in clinical stage IIA\/B metastatic seminoma: results of the Cologne trial of retroperitoneal lymphadenectomy in metastatic seminoma (COTRIMS)","volume":"7","author":"Heidenreich","year":"2024","journal-title":"Eur Urol Oncol"},{"key":"10.1016\/j.euf.2024.05.016_b0070","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1016\/S1470-2045(22)00564-2","article-title":"Single-dose carboplatin followed by involved-node radiotherapy for stage IIA and stage IIB seminoma (SAKK 01\/10): a single-arm, multicentre, phase 2 trial","volume":"23","author":"Papachristofilou","year":"2022","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.euf.2024.05.016_b0075","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1200\/JCO.2014.56.2116","article-title":"Patterns of relapse in patients with clinical stage I testicular cancer managed with active surveillance","volume":"33","author":"Kollmannsberger","year":"2015","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.euf.2024.05.016_b0080","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.eururo.2009.06.006","article-title":"Surveillance in stage I seminoma patients: a long-term assessment","volume":"57","author":"Cummins","year":"2010","journal-title":"Eur Urol"},{"key":"10.1016\/j.euf.2024.05.016_b0085","doi-asserted-by":"crossref","unstructured":"The International Prognostic Factors Study Group. Prognostic factors in patients with metastatic germ cell tumors who experienced treatment failure with cisplatin-based first-line chemotherapy. J Clin Oncol 2010;28:4906\u201311.","DOI":"10.1200\/JCO.2009.26.8128"}],"container-title":["European Urology Focus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405456924000798?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405456924000798?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,16]],"date-time":"2024-11-16T09:43:09Z","timestamp":1731750189000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405456924000798"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":17,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["S2405456924000798"],"URL":"https:\/\/doi.org\/10.1016\/j.euf.2024.05.016","relation":{},"ISSN":["2405-4569"],"issn-type":[{"type":"print","value":"2405-4569"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Review of Discordance Between American Urological Association and European Association of Urology Guideline Recommendations for Testicular Cancer","name":"articletitle","label":"Article Title"},{"value":"European Urology Focus","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.euf.2024.05.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 European Association of Urology. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}